RJA
EVLV icon

Raymond James & Associates’s Evolv Technologies EVLV Stock Holding History

Raymond James & Associates’s Portfolio EVLV Stock Details EVLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,500
Closed -$60.8K – 3873
2023
Q1 		$60.8K Buy
19,500
+7,500
+63% +$21.4K ﹤0.01% 3714
2022
Q4 		$31.1K Sell
12,000
-200
-2% -$589 ﹤0.01% 3757
2022
Q3 		$26K Buy
+12,200
New +$31.8K ﹤0.01% 3772

Other funds holding EVLV

GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's EVLV Position: Q2 2023 in Review

Raymond James & Associates sold out of Evolv Technologies (EVLV) in Q2 2023, closing a stake of 19,500 shares — an estimated $60.8K sold.

Raymond James & Associates first reported a position in EVLV in Q3 2022 and held it in 3 quarters. The position peaked at $60.8K in Q1 2023. 162 funds tracked by Wall St. Rank hold EVLV as of Q2 2023.

  • Raymond James & Associates reported no remaining Evolv Technologies position as of Q2 2023 after selling out during the quarter.
  • Raymond James & Associates sold 19,500 Evolv Technologies shares in Q2 2023, an estimated $60.8K.
  • Raymond James & Associates first reported a position in Evolv Technologies in Q3 2022 and held it in 3 quarters.
  • Raymond James & Associates's Evolv Technologies position peaked at $60.8K in Q1 2023.
  • 162 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2023.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.